Knowledge Hub · O-18 Enriched Water
The cyclotron does the heavy lifting on the ¹⁸O(p,n)¹⁸F reaction, but it can only work with what's in the target. This page unpacks the physics — why enrichment percentage scales with end-of-bombardment activity, what the conductivity and pyrogen specs prevent, what the per-batch CoA records, and what cold-chain import actually guarantees.
Why this matters
The 18O(p,n)18F reaction
The F-18 produced at the end of a cyclotron bombardment is the integral of the reaction cross section over the proton-energy spectrum, multiplied by the O-18 atom density in the target, multiplied by the beam current, multiplied by the irradiation time. Of those four, the O-18 atom density is the input the radiopharmacy controls. 98–99 % atom O-18 gives roughly a 2–4 % activity boost over 95–97 % grade at the same beam time — across a year of FDG production, that translates to additional patient doses per batch and a measurable reduction in beam-hours per dose.
Based on: IAEA TRS 471 — Cyclotron Produced Radionuclides; nuclear-data evaluations for the 18O(p,n)18F reaction.
Read source ↗Conductivity = parasitic radionuclides
Ionic impurities in the target water co-irradiate with the O-18 and produce parasitic radionuclides — Na-22 (t½ 2.6 y) from sodium, Co-58 / Co-60 from target-body contact, Cl-38 from chloride. These show up on the post-irradiation gamma spectrum as unexpected lines and contaminate the downstream FDG. A conductivity gate at < 3.0 µS/cm is the simplest verifiable proxy for the ionic-impurity load — below this threshold, the parasitic-radionuclide profile stays inside the Eur.Ph. monograph for FDG and equivalent F-18 tracers.
Based on: Eur.Ph. monograph 1325 — Fludeoxyglucose (18F) injection; IAEA cyclotron-target-material specifications.
Read source ↗Sterile + pyrogen-free input
The patient receives a downstream radiopharmaceutical (FDG, NaF, PSMA-1007). The target water itself is irradiated, reacted, separated and discarded — the patient does not contact it. But sterile / pyrogen-free input prevents two failure modes: (1) bacterial / endotoxin breakthrough into the synthesis-module reaction stream, which would contaminate the downstream product; (2) protein / lipid residues that would deposit on the target body during irradiation and degrade target performance over time. < 0.25 EU/mL LAL is the injectable-water spec applied to a cyclotron consumable.
Based on: USP <85> Bacterial Endotoxins Test; Eur.Ph. 2.6.14 Bacterial Endotoxins; IAEA Operational Guidance on Hospital Radiopharmacy.
Read source ↗Per-batch CoA as the GMP file entry
The per-batch CoA records: isotopic composition (atom % O-16 / O-17 / O-18), chemical purity, conductivity, pH, TOC, sterility test, LAL pyrogen test, halide panel, metal panel, anion panel. Each value carries a numeric result and a spec limit. The CoA is the input-material qualification record for the cyclotron GMP file — AERB inspection reads it as the chain-of-custody document for the target-loading workflow.
Based on: AERB Safety Code for Medical Cyclotron Facility; EU GMP Annex 3 — Manufacture of Radiopharmaceuticals.
Read source ↗Recovery + recycling economics
Post-irradiation, the target water is passed through an anion-exchange column to capture F-18 for the synthesis module. The water that comes off the column is depleted in O-18 by the small fraction transmuted to F-18 — typically < 1 % of the O-18 inventory per shot. For high-volume sites that recycle target water, starting with 98–99 % atom O-18 means the recovered water stays above the lower-bound spec for many cycles. The cost-per-shot drops; the per-dose economics improve.
Based on: IAEA TRS 471 — Cyclotron Produced Radionuclides (chapter on target-water recovery); EANM cyclotron-radiopharmacy practice notes.
Read source ↗Cold-chain + AERB import
Cyclotron-grade O-18 water is an AERB / CDSCO controlled-import consumable. Cold-chain delivery preserves chemical and microbiological integrity from manufacture to target loading; a transport logger is packed with each lot to evidence chain continuity. The AERB import paperwork covers per-lot identity, per-lot CoA, and the consignee cyclotron facility licence number. Lot release at the receiving radiopharmacy verifies the CoA against the lot, archives it in the GMP file, and signs the lot into the consumable inventory.
Based on: AERB import-licensing framework for cyclotron consumables; CDSCO drug-and-cosmetic import provisions.
Read source ↗IAEA, Eur.Ph. and AERB documents that anchor cyclotron target-water qualification and the downstream FDG release.
IAEA technical report on cyclotron-produced radionuclide chemistry, target-material specifications and recovery practice.
European Pharmacopoeia monograph defining purity and radionuclide expectations for the downstream FDG product the target water feeds.
IAEA technical report covering PET radiopharmacy QC including input-material qualification expectations.
Indian regulatory framework for medical cyclotron facility licensing including consumable qualification expectations.
Where next